GlassScriptPhysician profile
Rakesh Shah
NPI 1144297219
$220,606.82
in general payments reported to CMS, 2019-2025
48 companies · $88K in 2025
The $88K reported for 2025 was more than what 99% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,415 · 2020: $11K · 2021: $32K · 2022: $9,573 · 2023: $11K · 2024: $65K · 2025: $88K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $145K · Travel and Lodging: $9,870 · Food and Beverage: $9,365.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $144,694.50 |
| Travel and Lodging | $9,869.56 |
| Food and Beverage | $9,364.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $109,268.97 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Boston Scientific Corporation | $51,214.17 | 2019-2025 | Watchman Access System, Watchman Flx, Bodyguardian |
| Astrazeneca Pharmaceuticals LP | $34,244.60 | 2019-2025 | Lokelma, Farxiga, Wainua |
| Esperion Therapeutics, INC. | $17,150.13 | 2021-2024 | Nexletol |
| Impulse Dynamics (USA) INC. | $1,214.91 | 2022-2025 | Optimizer, Optimizer |
| Janssen Pharmaceuticals, INC | $1,134.22 | 2019-2024 | Xarelto |
| Novartis Pharmaceuticals Corporation | $802.64 | 2019-2025 | |
| Amgen INC. | $799.10 | 2019-2025 | Evenity, Repatha, Repatha |
| Sanofi-Aventis U.S. LLC | $674.92 | 2019-2020 | |
| Pfizer INC. | $634.15 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $501.26 | 2020-2025 | Camzyos, Eliquis |
| Endologix LLC | $327.82 | 2025 | Endocross Device, Torus Stent Graft System |
| Merck Sharp & Dohme LLC | $288.73 | 2021-2025 | Verquvo |
| Agepha Pharma Fz LLC | $207.18 | 2024 | Lodoco |
| Bardy Diagnostics, INC. | $192.41 | 2020-2021 |
Show all 48 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $177.44 | 2019-2023 | |
| Alnylam Pharmaceuticals INC. | $171.97 | 2024-2025 | Onpattro, Amvuttra |
| Abiomed | $164.35 | 2023 | Impella |
| Abbott Laboratories | $144.76 | 2022-2024 | Mitraclip |
| Glaxosmithkline, LLC. | $111.57 | 2020 | |
| Astellas Pharma US INC | $80.67 | 2020-2021 | |
| Altathera Pharmaceuticals LLC | $79.43 | 2022-2023 | Sotalol Hydrochloride |
| Vital Connect, INC | $76.07 | 2023 | Vitalpatch Rtm |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $76.06 | 2019-2025 | Lifevest |
| Medtronic, INC. | $74.84 | 2023 | Endurant Iis |
| Regeneron Healthcare Solutions, INC. | $69.28 | 2019-2024 | Evkeeza |
| Bayer Healthcare Pharmaceuticals INC. | $69.02 | 2021-2025 | |
| Lexicon Pharmaceuticals, INC. | $61.97 | 2023-2024 | Inpefa |
| Portola Pharmaceuticals, LLC | $61.89 | 2019-2020 | |
| Kestra Medical Technology Services, INC. | $53.99 | 2022 | |
| Bridgebio Pharma, INC. | $53.38 | 2025 | Attruby |
| Kowa Pharmaceuticals America, INC. | $48.61 | 2019-2021 | |
| Althera Pharmaceuticals LLC | $44.42 | 2021 | |
| Cook Medical LLC | $37.39 | 2019-2020 | |
| Kiniksa Pharmaceuticals, LTD. | $36.40 | 2023 | Arcalyst |
| Lundbeck LLC | $29.79 | 2019-2020 | |
| Edwards Lifesciences Corporation | $29.13 | 2024 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Daiichi Sankyo INC. | $26.72 | 2024 | Injectafer |
| Baxter Healthcare | $26.14 | 2025 | Hillrom - Cardiac Ambulatory Monitor |
| W. L. Gore & Associates, INC. | $25.02 | 2019 | |
| Eisai INC. | $24.19 | 2020 | |
| Xeris Pharmaceuticals, INC. | $21.82 | 2023 | Gvoke Hypopen |
| Inspire Medical Systems, INC. | $17.00 | 2024 | Inspire |
| Medtronic Vascular, INC. | $15.79 | 2020 | |
| Lilly USA, LLC | $14.82 | 2022 | |
| Scpharmaceuticals INC. | $13.34 | 2024 | |
| Janssen Biotech, INC. | $7.94 | 2019 | |
| Endotronix, INC. | $6.40 | 2024 | Cordella Pulomonary Artery Pressure Sensor |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rakesh Shah listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.